The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.
Pathogenesis of systemic lupus erythematosus
Open accessAbstract
The exact patho-aetiology of systemic lupus erythematosus (SLE) remains elusive. An extremely complicated and multifactorial interaction among various genetic and environmental factors is probably involved. Multiple genes contribute to disease susceptibility. The interaction of sex, hormonal milieu, and the hypothalamo–pituitary–adrenal axis modifies this susceptibility and the clinical expression of the disease. Defective immune regulatory mechanisms, such as the clearance of apoptotic cells and immune complexes, are important contributors to the development of SLE. The loss of immune tolerance, increased antigenic load, excess T cell help, defective B cell suppression, and the shifting of T helper 1 (Th1) to Th2 immune responses leads to B cell hyperactivity and the production of pathogenic autoantibodies. Finally, certain environmental factors are probably required to trigger the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., & Nagata, S. (1994) · Cell · doi:10.1016/0092-8674(94)90375-1 · Cited by 1,528
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434
CERVERA, R., KHAMASHTA, M. A., FONT, J., SEBASTIANI, G. D., GIL, A., LAVILLA, P., DOMÉNECH, I., AYDINTUG, A. O., JEDRYKA-GÓRAL, A., RAMÓN, E. D., et al. (1993) · Medicine · doi:10.1097/00005792-199303000-00005 · Cited by 979
Repeat-induced gene silencing in mammals
Garrick, D., Fiering, S., Martin, D. I. K., & Whitelaw, E. (1998) · Nature Genetics · doi:10.1038/ng0198-56 · Cited by 887
Herrmann, M., Voll, R. E., Zoller, O. M., Hagenhofer, M., Ponner, B. B., & Kalden, J. R. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199807)41:7<1241::aid-art15>3.0.co;2-h · Cited by 839
Sternberg, E. M., Hill, J. M., Chrousos, G. P., Kamilaris, T., Listwak, S. J., Gold, P. W., & Wilder, R. L. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2374 · Cited by 723
Hahn, B. H. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805073381906 · Cited by 682
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 657
Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.
Mohan, C., Adams, S., Stanik, V, & Datta, S. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1367 · Cited by 627
Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.
Emlen, W., Niebur, J., & Kadera, R. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.7.3685 · Cited by 552
Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis
Linker-Israeli, M., Deans, R. J., Wallace, D. J., Prehn, J., Ozeri-Chen, T., & Klinenberg, J. R. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.117 · Cited by 549
Etiopathogenesis of Murine SLE1
THEOFILOPOULOS, A. N., & Dixon, F. J. (1981) · Immunological Reviews · doi:10.1111/j.1600-065x.1981.tb00343.x · Cited by 511
Cleavage by Granzyme B Is Strongly Predictive of Autoantigen Status
Casciola-Rosen, L., Andrade, F., Ulanet, D., Wong, W. B., & Rosen, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.6.815 · Cited by 492
Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.
Wu, J., Wilson, J., He, J., Xiang, L., Schur, P. H., & Mountz, J. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118892 · Cited by 472
Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans.
Salmon, J. E., Millard, S., Schachter, L. A., Arnett, F. C., Ginzler, E. M., Gourley, M. F., Ramsey-Goldman, R., Peterson, M. G., & Kimberly, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118552 · Cited by 469
Linker-Israeli, M., Bakke, A. C., Kitridou, R. C., Gendler, S., Gillis, S., & Horwitz, D. A. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.6.2651 · Cited by 452
Alcocer-Varela, J., & Alarcón-Segovia, D. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110579 · Cited by 420
C1q and Systemic Lupus Erythematosus
Walport, M. J., Davies, K. A., & Botto, M. (1998) · Immunobiology · doi:10.1016/s0171-2985(98)80032-6 · Cited by 393
James, J. A., Gross, T., Scofield, R. H., & Harley, J. B. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.453 · Cited by 339
Llorente, L., Richaud‐Patin, Y., Fior, R., Alcocer‐Varela, J., Wijdenes, J., Fourrier, B. M., Galanaud, P., & Emilie, D. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780371114 · Cited by 313
GENETIC SUSCEPTIBILITY TO SYSTEMIC LUPUS ERYTHEMATOSUS
Vyse, T. J., & Kotzin, B. L. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.261 · Cited by 313
Prevention of relapses in systemic lupus erythematosus
Bootsma, H., Spronk, P., de Boer, G., Limburg, P., Kallenberg, C., Derksen, R., Wolters-Dicke, J., Gmelig-Meyling, F., Kater, L., & Hermans, J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90114-0 · Cited by 290
Hagiwara, E., Gourley, M. F., Lee, S., & Klinman, D. M. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390305 · Cited by 287
Cytokine production, serum levels and disease activity in systemic lupus erythematosus.
Gröndal, G., Gunnarsson, I., Rönnelid, J., Rogberg, S., Klareskog, L., & Lundberg, I. E. (2000) · PubMed · Cited by 287
Low plasma androgens in women with systemic lupus erythematosus
Lahita, R. G., Bradlow, H. L., Ginzler, E., Pang, S., & New, M. (1987) · Arthritis & Rheumatism · doi:10.1002/art.1780300301 · Cited by 284
Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity
Houssiau, F., Lefebvre, C., Vanden Berghe, M., Lambert, M., Devogelaer, J.-P., & Renauld, J.-C. (1995) · Lupus · doi:10.1177/096120339500400510 · Cited by 281
Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells.
Suzuki, T., Suzuki, N., Daynes, R. A., & Engleman, E. G. (1991) · Clinical Immunology and Immunopathology · doi:10.1016/s0090-1229(05)80024-8 · Cited by 277
Estrogen enhances immunoglobulin production by human PBMCs
Kanda, N., & Tamaki, K. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70503-8 · Cited by 272
Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus
Jungers, P., Dougados, M., Pélissier, C., Kuttenn, F., Tron, F., Lesavre, P., & Bach, J.-F. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250603 · Cited by 269
Sthoeger, Z. M., Chiorazzi, N., & Lahita, R. G. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.1.91 · Cited by 247
Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus.
Park, Y.-B., Lee, S., Kim, D. S., Lee, J. W., Lee, C. H., & Song, C. H. (1998) · PubMed · Cited by 246
Furukawa, F., Kashihara-Sawami, M., Lyons, M. B., & Norris, D. A. (1990) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12873930 · Cited by 243
Vlahakos, D., Foster, M. H., Ucci, A. A., Barrett, K. J., Datta, S. K., & Madaio, M. P. (1992) · Journal of the American Society of Nephrology · doi:10.1681/asn.v281345 · Cited by 241
Liossis, S. N., Kovacs, B., Dennis, G., Kammer, G. M., & Tsokos, G. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119073 · Cited by 225
Horwitz, D. A., Gray, J. D., Behrendsen, S. C., Kubin, M. Z., Rengaraju, M., Ohtsuka, K., & Trinchieri, G. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199805)41:5<838::aid-art10>3.0.co;2-s · Cited by 223
Alterations of estrogen metabolism in systemic lupus erythematosus
Lahita, R. G., Leon Bradlow, H., Kunkel, H. G., & Fishman, J. (1979) · Arthritis & Rheumatism · doi:10.1002/art.1780221106 · Cited by 220
Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice
Ehrenstein, M. R., Katz, D. R., Griffiths, M. H., Papadaki, L., Winkler, T. H., Kalden, J. R., & Isenberg, D. A. (1995) · Kidney International · doi:10.1038/ki.1995.341 · Cited by 220
Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells
Kanda, N., Tsuchida, T., & Tamaki, K. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-842.x · Cited by 216
Llorente, L., Richaud‐Patín, Y., Wijdenes, J., Alcocer-Varela, J. C., Maillot, M. C., Durand–Gasselin, I., Fourrier, B. M., Galanaud, P., & Émilie, D. (1993) · PubMed · Cited by 203
Postmenopausal Estrogen Therapy and the Risk for Developing Systemic Lupus Erythematosus
Sanchez-Guerrero, J., Liang, M. H., Karlson, E. W., Hunter, D. J., & Colditz, G. A. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-6-199503150-00005 · Cited by 201
Kanda, N., Tsuchida, T., & Tamaki, K. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199902)42:2<328::aid-anr16>3.0.co;2-# · Cited by 184
Gender and risk of autoimmune diseases: possible role of estrogenic compounds.
Ahmed, S. A., Hissong, B. D., Verthelyi, D., Donner, K., Becker, K., & Karpuzoglu-Sahin, E. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107s5681 · Cited by 182
Past use of oral contraceptives and the risk of developing systemic lupus erythematosus
Sanchez‐Guerrero, J., Karlson, E. W., Liang, M. H., Hunter, D. J., Speizer, F. E., & Colditz, G. A. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400505 · Cited by 177
Casciola-Rosen, L. A., & Rosen, A. (1997) · Lupus · doi:10.1177/096120339700600213 · Cited by 172
Impairment of CD8+ T Suppressor Cell Function in Patients with Active Systemic Lupus Erythematosus
Filaci, G., Bacilieri, S., Fravega, M., Monetti, M., Contini, P., Ghio, M., Setti, M., Puppo, F., & Indiveri, F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6452 · Cited by 165
Gray‐McGuire, C., Moser, K. L., Gaffney, P. M., Kelly, J. A., Yu, H., Olson, J. M., Jedrey, C. M., Jacobs, K. B., Kimberly, R. P., Neas, B. R., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316891 · Cited by 149
Lavalle, C. M., Loyo, E., Paniagua, R., Bermúdez, J. A., Herrera, J., Graef, A., González-Bárcena, D., & Fraga, A. (1987) · PubMed · Cited by 148
Csiszár, A., Nagy, G. Y., Gergely, P., Pozsonyi, T., & Pócsik, É. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01369.x · Cited by 147
Immunosuppression by sex steroid hormones. The effect upon PHA- and PPD-stimulated lymphocytes.
Wyle, F. A., & Kent, J. R. (1977) · PubMed · Cited by 144
Nucleosomes and histones are present in glomerular deposits in human lupus nephritis
van Bruggen, M. C. J., Kramers, C., Walgreen, B., Elema, J., Kallenberg, C. G. M., van den Born, J., Smeenk, R. J. T., Assmann, K. J. M., Muller, S., Monestier, M., et al. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.1.57 · Cited by 140
Hyperprolactinemia in Systemic Lupus Erythematosus: Association with Disease Activity
Jara, L. J., Gómez-Sánchez, C. E., Silveira, L. H., Martínez-Osuna, P., Vasey, F. B., & Espinoza, L. R. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199204000-00003 · Cited by 137
Kanda, N., Tsuchida, T., & Tamaki, K. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400921 · Cited by 133
Mh, F., Cizman, B., & Madaio, M. P. (1993) · PubMed · Cited by 125
Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus.
McMurray, R. W., Weidensaul, D., Allen, S. H., et al. (1995) · PubMed · Cited by 123
Ip, W., Chan, S. Y., Lau, C. S., & Lau, Y. (1998) · PubMed · Cited by 120
Self-citationT FcRIIIA158F allele is a risk factor for systemic lupus erythematosus
Koene, H. R., Kleijer, M., Swaak, A. J. G., Sullivan, K. E., Bijl, M., Petri, M., Kallenberg, C. G. M., Roos, D., Borne, A. E. G. K. V. D., & de Haas, M. (1998) · Arthritis & Rheumatism · Cited by 119
Low plasma androgens in women with active or quiescent systemic lupus erythematosus
Jungers, P., NAHOUL, K., Pelissier, C., Dougados, M., Tron, F., & Bach, J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780250415 · Cited by 115
Diethylstilboestrol: II, pharmacology, toxicology and carcinogenicity in experimental animals
Μαρσέλος, Μ., & Tomatis, L. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90597-9 · Cited by 114
Julkunen, H. A. (1991) · Scandinavian Journal of Rheumatology · doi:10.3109/03009749109096822 · Cited by 109
17-β-ESTRADIOL SUPPRESSES IL-2 AND IL-2 RECEPTOR
McMurray, R. W., Ndebele, K., Hardy, K. J., & Jenkins, J. K. (2001) · Cytokine · doi:10.1006/cyto.2001.0900 · Cited by 108
Epitope spreading in systemic lupus erythematosus: Identification of triggering peptide sequences
Monneaux, F., & Muller, S. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10263 · Cited by 106
Pregnancy in systemic lupus erythematosus
Mok, C. C., & Wong, R. W. S. (2001) · Postgraduate Medical Journal · doi:10.1136/pmj.77.905.157 · Cited by 105
Self-citationIncreased occurrence of autoimmune disease among women exposed in utero to diethylstilbestrol
Noller, K. L., Blair, P. B., O’Brien, P. C., Melton, L. J., Offord, J. R., Kaufman, R. H., & Colton, T. (1988) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59965-8 · Cited by 102
T Lymphocyte Subsets in Systemic Lupus Erythematosus
Bakke, A. C., Kirkland, P. A., Kitridou, R. C., Quismorio, F. P., Rea, T. H., Ehresmann, G. R., & Horwitz, D. A. (1983) · Arthritis & Rheumatism · doi:10.1002/art.1780260607 · Cited by 100
Shoshan, Y., Shapira, I., Toubi, E., Frolkis, I., Yaron, M., & Mevorach, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5963 · Cited by 99
Antibodies to C1q in systemic lupus erythematosus: Characteristics and relation to FcγRIIA alleles
Haseley, L. A., Wisnieski, J. J., Denburg, M., Michael-Grossman, A. R., Ginzler, E. M., Gourley, M. F., Hoffman, J. H., Kimberly, R. P., & Salmon, J. E. (1997) · Kidney International · doi:10.1038/ki.1997.464 · Cited by 98
Evans, M. J., MacLaughlin, S., Marvin, R. D., & Abdou, N. I. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1996.4300 · Cited by 96
Plasma Sex Hormones and Aromatase Activity in Tissues of Patients with Systemic Lupus Erythematosus
Folomeev, M., Dougados, M., Beaune, J., Kouyoumdjian, J. C., NAHOUL, K., Amor, B., & Alekberova, Z. S. (1992) · Lupus · doi:10.1177/096120339200100312 · Cited by 96
Profile of sex hormones in male patients with systemic lupus erythematosus
Mok, C. C., & Lau, C. S. (2000) · Lupus · doi:10.1191/096120300680198926 · Cited by 96
Self-citationGENETICS OF SYSTEMIC LUPUS ERYTHEMATOSUS
Sullivan, K. E. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70137-x · Cited by 93
Bromocriptine restores tolerance in estrogen-treated mice
Peeva, E., Grimaldi, C. M., Spatz, L. A., & Diamond, B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10420 · Cited by 93
Buskila, D., Lorber, M., Neumann, L., et al. (1996) · PubMed · Cited by 87
Meier, C. R., Sturkenboom, M., Cohen, A. S., et al. (1998) · PubMed · Cited by 84
Increased oxidation of testosterone in systemic lupus erythematosus
Lahita, R. G., Kunkel, H. G., & Bradlow, H. L. (1983) · Arthritis & Rheumatism · doi:10.1002/art.1780261215 · Cited by 83
Pacilio, M., Migliaresi, S., Meli, R., et al. (2001) · PubMed · Cited by 82
Suzuki, T., Suzuki, N., Engleman, E. G., Mizushima, Y., & Sakane, T. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb05541.x · Cited by 81
Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus.
Rider, V., Jones, S. A., Evans, M. W., et al. (2001) · PubMed · Cited by 78
Hair dye use and the risk of developing systemic lupus erythematosus: A cohort study
Sánchez‐Guerrero, J., Karlson, E. W., Colditz, G. A., Hunter, D. J., Speizer, F. E., & Liang, M. H. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390418 · Cited by 78
Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus
Gutiérrez, M. A., García, M. E., Rodríguez, J. A., Rivero, S., & Jacobelli, S. H. (1998) · Lupus · doi:10.1191/096120398678920343 · Cited by 73
Courtney, P. A., Crockard, A. D., Williamson, K., et al. (1999) · Lupus · doi:10.1191/096120399678840765 · Cited by 70
Modulation of the expression of murine lupus by gonadotropin-releasing hormone analogs
Jacobson, J. D., Nisula, B. C., & Steinberg, A. D. (1994) · Endocrinology · doi:10.1210/endo.134.6.8194477 · Cited by 69
CONNECTIVE TISSUE DISEASE IN SOUTHEASTERN GEORGIA: A CASE-CONTROL STUDY OF ETIOLOGIC FACTORS
Freni-Titulaer, L. W., KELLEY, D. B., GROW, A. G., McKinley, T. W., Arnett, F. C., & Hochberg, M. C. (1989) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115348 · Cited by 67
Rider, V., Foster, R. T., Evans, M. J., Suenaga, R., & Abdou, N. I. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1998.4604 · Cited by 67
Action of Pituitary and Lymphocyte Prolactin
Matera, L. (2010) · NeuroImmunoModulation · doi:10.1159/000097335 · Cited by 65
Prolactin and autoimmune disease
Walker, S. E., Allen, S. H., & McMurray, R. W. (1993) · Trends in Endocrinology and Metabolism · doi:10.1016/1043-2760(93)90103-l · Cited by 61
Lechner, O., Dietrich, H., dos Santos, A. O., Wiegers, G. J., Schwarz, S., Harbutz, M., Herold, M., & Wick, G. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.2000.0375 · Cited by 61
Systemic lupus erythematosus and Klinefelter's syndrome.
French, M. A., & Hughes, P. J. (1983) · Annals of the Rheumatic Diseases · doi:10.1136/ard.42.4.471 · Cited by 61
Clinical significance of serum and urine prolactin levels in lupus glomerulonephritis
Miranda, J. M., Prieto, R. E., Paniagua, R., García, G., Amato, D., Barile, L., & Jara, L. J. (1998) · Lupus · doi:10.1191/096120398678920307 · Cited by 60
Systemic Lupus Erythematosus: Sex Hormones in Male Patients
Sequeira, J., Keser, G., Greenstein, B., Wheeler, M. J., Duarte, P. C. X., Khamashta, M. A., & Hughes, R. R. V. (1993) · Lupus · doi:10.1177/096120339300200507 · Cited by 59
Lauwerys, B. R., Garot, N., Renauld, J., & Houssiau, F. A. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200009)43:9<1976::aid-anr8>3.0.co;2-v · Cited by 51
Potentiation of antibody responsiveness after the transplantation of a syngeneic pituitary gland
Cross, R. J., Campbell, J. L., & Roszman, T. L. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90083-0 · Cited by 51
The role of apoptosis in systemic lupus erythematosus
Salmon, M., & Gordon, C. (1999) · Rheumatology · doi:10.1093/rheumatology/38.12.1177 · Cited by 50
An update on genetic studies of systemic lupus erythematosus
Tsao, B. P. (2002) · Current Rheumatology Reports · doi:10.1007/s11926-002-0046-5 · Cited by 49
Garcia-Cozar, F. J., Molina, I. J., Cuadrado, M. J., Marubayashi, M., Peña, J., & Santamaria, M. L. (1996) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-648.x · Cited by 49
Yudoh, K., Matsuno, H., Nakazawa, F., Yonezawa, T., & Kimura, T. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199909)42:9<1902::aid-anr16>3.0.co;2-g · Cited by 48
Complement activation and complement receptors in systemic lupus erythematosus
Atkinson, J. P. (1986) · Springer Seminars in Immunopathology · doi:10.1007/bf02099021 · Cited by 47
Hair product use in systemic lupus erythematosus. A case‐control study
Petri, M., & Allbritton, J. I. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350605 · Cited by 46
Use of exogenous estrogens in systemic lupus erythematosus
Mok, C. C., Lau, C. S., & Wong, R. W. S. (2001) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2001.22498 · Cited by 43
Self-citationTyrrell-Price, J., Lydyard, P. M., & Isenberg, D. A. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01466.x · Cited by 42
Retroviruses and Systemic Lupus Erythematosus
i, M. H., Hagenhofer, M., & Kalden, J. R. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00914.x · Cited by 42
Shanks, N. M., Moore, P. M., Perks, P., & Lightman, S. L. (1999) · Brain Behavior and Immunity · doi:10.1006/brbi.1998.0535 · Cited by 41
Berczi, I. (1992) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-1018876 · Cited by 40
The effect of LHRH and TRH on human interferon-γ production in vivo and in vitro
Grasso, G., Massai, L., Leo, V. D., & Muscettola, M. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00172-6 · Cited by 38
Houssiau, F. A., Mascart-Lemone, F., Stevens, M., et al. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.d01-1009.x · Cited by 36
Jacobson, J. D., Ansari, M. A., Kinealy, M., & Muthukrishnan, V. (1999) · Endocrinology · doi:10.1210/endo.140.8.6892 · Cited by 34
Prolactin profile in a cohort of Chinese systemic lupus erythematosus patients
Mok, C. C., Lau, C. S., & Tam, S. (1997) · Lara D. Veeken · doi:10.1093/rheumatology/36.9.986 · Cited by 32
Self-citationThe mechanism of action of L‐canavanine in inducing autoimmune phenomena
Alcocer-Varela, J. C., & Alarcón-Segovia, D. (1985) · Arthritis & Rheumatism · doi:10.1002/art.1780281022 · Cited by 30
Petri, M. (2001) · Lupus · doi:10.1191/096120301676707393 · Cited by 28
Defective early T and T-dependent B cell activation in systemic lupus erythematosus
Fernández‐Gutiérrez, B., Miguel, S. D., Morado, C., Hernández‐García, C., Bañares, A. A., & Jover, J. Á. (1998) · Lupus · doi:10.1191/096120398678920226 · Cited by 22
08 Genetics of systemic lupus erythematosus
Padyukov, L. (2024) · Lupus Science & Medicine · doi:10.1136/lupus-2024-la.8 · Cited by 8
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5
Neidhart (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200012)43:12 · Cited by 1
Cited by
Merrill, J. T., Neuwelt, C. M., Wallace, D. J., Shanahan, J. C., Latinis, K. M., Oates, J. C., Utset, T. O., Gordon, C., Isenberg, D. A., Hsieh, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27233 · Cited by 1,409
Tian, J., Avalos, A. M., Mao, S.-Y., Chen, B., Senthil, K., Wu, H., Parroche, P., Drabic, S., Golenbock, D., Sirois, C., et al. (2007) · Nature Immunology · doi:10.1038/ni1457 · Cited by 1,372
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Angelin, A., Gil-de-Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, W. J., Kopinski, P. K., Wang, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.018 · Cited by 1,246
Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9
Means, T. K., Latz, E., Hayashi, F., Murali, M. R., Golenbock, D. T., & Luster, A. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523025 · Cited by 849
Urbonaviciute, V., Fürnrohr, B. G., Meister, S., Munoz, L., Heyder, P., De Marchis, F., Bianchi, M. E., Kirschning, C., Wagner, H., Manfredi, A. A., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081165 · Cited by 517
Metadata
- Authors
- Mok, C. C., & Lau, C. S.
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 2003-07
- Volume
- 56
- Issue
- 7
- Pages
- 481-490
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- OpenAlex
- W2016318369
- Cited by
- 942
- References
- 114
- FWCI
- 18.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.